Literature DB >> 27156052

The rising cost of diabetes care in the USA.

Patricia Peter1, Kasia Lipska2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27156052      PMCID： PMC5380140          DOI： 10.1016/S2213-8587(15)00519-7

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  9 in total

1.  Measuring the Value of Prescription Drugs.

Authors:  Peter J Neumann; Joshua T Cohen
Journal:  N Engl J Med       Date:  2015-11-18       Impact factor: 91.245

2.  Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs.

Authors:  Peter B Bach; Steven D Pearson
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

3.  Achievement of goals in U.S. Diabetes Care, 1999-2010.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Edward W Gregg
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

4.  Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011.

Authors:  Harlan M Krumholz; Sharon-Lise T Normand; Yun Wang
Journal:  Circulation       Date:  2014-08-18       Impact factor: 29.690

5.  Change in medical spending attributable to diabetes: national data from 1987 to 2011.

Authors:  Xiaohui Zhuo; Ping Zhang; Henry S Kahn; Barbara H Bardenheier; Rui Li; Edward W Gregg
Journal:  Diabetes Care       Date:  2015-01-15       Impact factor: 19.112

6.  Changes in diabetes-related complications in the United States, 1990-2010.

Authors:  Edward W Gregg; Yanfeng Li; Jing Wang; Nilka Rios Burrows; Mohammed K Ali; Deborah Rolka; Desmond E Williams; Linda Geiss
Journal:  N Engl J Med       Date:  2014-04-17       Impact factor: 91.245

7.  National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.

Authors:  Kasia J Lipska; Joseph S Ross; Yun Wang; Silvio E Inzucchi; Karl Minges; Andrew J Karter; Elbert S Huang; Mayur M Desai; Thomas M Gill; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

8.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

9.  Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.

Authors:  Lydia W Turner; David Nartey; Randall S Stafford; Sonal Singh; G Caleb Alexander
Journal:  Diabetes Care       Date:  2013-11-06       Impact factor: 17.152
  9 in total
  10 in total

1.  Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.

Authors:  Vincent J Willey; Sheldon Kong; Bingcao Wu; Amit Raval; Todd Hobbs; Andrea Windsheimer; Gaurav Deshpande; Ozgur Tunceli; Brian Sakurada; Jonathan R Bouchard
Journal:  Am Health Drug Benefits       Date:  2018-09

2.  miR-199a-5p Plays a Pivotal Role on Wound Healing via Suppressing VEGFA and ROCK1 in Diabetic Ulcer Foot.

Authors:  Hongshu Wang; Xianyi Wang; Xiaomin Liu; Jinbao Zhou; Qianqian Yang; Binshu Chai; Yimin Chai; Zhongliang Ma; Shengdi Lu
Journal:  Oxid Med Cell Longev       Date:  2022-04-07       Impact factor: 7.310

3.  Health Insurance Is Associated with Decreased Odds for Undiagnosed Prediabetes and Type 2 Diabetes in American Adults.

Authors:  Sean Mahoney; Adam Bradley; Logan Pitts; Stephanie Waletzko; Sheria G Robinson-Lane; Timothy Fairchild; Donna J Terbizan; Ryan McGrath
Journal:  Int J Environ Res Public Health       Date:  2020-06-30       Impact factor: 3.390

4.  Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory.

Authors:  Enzo Bonora; Salvatore Cataudella; Giulio Marchesini; Roberto Miccoli; Olga Vaccaro; Gian Paolo Fadini; Nello Martini; Elisa Rossi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

Review 5.  The Role of the Gut Microbiota in the Pathogenesis of Diabetes.

Authors:  Weronika Bielka; Agnieszka Przezak; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

6.  GoFundMe as a Medical Plan: Ecological Study of Crowdfunding Insulin Success.

Authors:  Julia E Blanchette; M J Tran; Ernest G Grigorian; Eli Iacob; Linda S Edelman; Tamara K Oser; Michelle L Litchman
Journal:  JMIR Diabetes       Date:  2022-04-15

7.  Indication-wide drug pricing: Insights from the pharma market.

Authors:  Florian Siegmeier; Melanie Büssgen
Journal:  J Pharm Policy Pract       Date:  2022-08-29

8.  Varying levels of depressive symptoms and lifestyle health behaviors in a low income, urban population.

Authors:  Brenda Robles; Mirna Ponce Jewell; Courtney S Thomas Tobin; Lisa V Smith; Tony Kuo
Journal:  J Behav Med       Date:  2020-09-16

9.  Diabetes classification model based on boosting algorithms.

Authors:  Peihua Chen; Chuandi Pan
Journal:  BMC Bioinformatics       Date:  2018-03-27       Impact factor: 3.169

10.  Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary care.

Authors:  Michelle Greiver; Alys Havard; Juliana Kf Bowles; Sumeet Kalia; Tao Chen; Babak Aliarzadeh; Rahim Moineddin; Julian Sherlock; William Hinton; Frank Sullivan; Braden O'Neill; Conrad Pow; Aashka Bhatt; Fahurrozi Rahman; Bernardo Meza-Torres; Melisa Litchfield; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2021-02-25       Impact factor: 6.302
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.